Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

BioInvent International

23.10 SEK

+3.82 %

Less than 1K followers

BINV

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioInvent International

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue12.821.444.722.1198.13.33.0226.5
EBITDA-102.3-121.0-451.8-117.734.1-128.8-119.5-331.8
EBIT-107.2-125.9-471.1-122.834.1-133.6-129.4-351.7
EBIT-%-839.7 %-589.0 %-1,054.1 %-556.6 %17.2 %-4,023.1 %-4,285.1 %-155.3 %
Profit before taxes-97.2-116.8-429.2-116.638.9-129.1-125.6-332.5
Net income-97.2-116.9-429.4-116.638.8-129.2-125.8-332.9
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.